The safety of MSC therapy over the past 15 years: a meta-analysis

BACKGROUND: Despite increasing clinical investigations emphasizing the safety of mesenchymal stem cell (MSC) therapy in different populations with different diseases, no article has recently reviewed the adverse events in all populations. AIM: To evaluate the safety of MSC therapy in all populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Yi, Hanxiao, Song, Yancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522073/
https://www.ncbi.nlm.nih.gov/pubmed/34663461
http://dx.doi.org/10.1186/s13287-021-02609-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522073/
https://www.ncbi.nlm.nih.gov/pubmed/34663461
http://dx.doi.org/10.1186/s13287-021-02609-x

Ejemplares similares